[Agents to improve cerebrovascular circulation and cerebral metabolism--general concepts and classification of the drugs].
Hirai
S
S
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000145:classification; D000318:Adrenergic beta-Agonists / Q000145:classification; D001921:Brain / Q000378:metabolism*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003574:Cytochrome c Group / Q000494:pharmacology; D006801:Humans; D010101:Oxygen Consumption / Q000187:drug effects; D014665:Vasodilator Agents / Q000145:classification* / Q000494:pharmacology / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D003574:Cytochrome c Group; D014665:Vasodilator Agents; D005680:gamma-Aminobutyric Acid; D000255:Adenosine Triphosphate